Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020

Abstract

Background. Cholecalciferol is used in a minority of patients due to fear of prolonged hypercalcemia and renal toxicity